D-10 Therapeutics, Inc

www.d10therapeutics.com

We are an early stage biotech company that has created a monoclonal antibody(s) for the treatment of Sickle Cell Disease. We are targeting a receptor that has ubiquitous possibilities. Our goal is to provide the global village access to compounds that improve patients' quality of life and outcomes through our novel scientific technology. D-10 strives to make our monoclonal antibody(s) available at an affordable price for the patient population that we serve.

Read more

Reach decision makers at D-10 Therapeutics, Inc

Lusha Magic

Free credit every month!

We are an early stage biotech company that has created a monoclonal antibody(s) for the treatment of Sickle Cell Disease. We are targeting a receptor that has ubiquitous possibilities. Our goal is to provide the global village access to compounds that improve patients' quality of life and outcomes through our novel scientific technology. D-10 strives to make our monoclonal antibody(s) available at an affordable price for the patient population that we serve.

Read more
icon

Country

icon

State

California

icon

City (Headquarters)

Torrance

icon

Employees

1-10

icon

Founded

2017

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Co - Founder , Chief Financial Officer and Business Development

    Email ****** @****.com
    Phone (***) ****-****

Reach decision makers at D-10 Therapeutics, Inc

Free credits every month!

My account

Sign up now to uncover all the contact details